Core Viewpoint - 康臣药业 has been actively repurchasing its shares, indicating a strategy to support its stock price amidst recent declines [2][3] Summary by Category Share Buyback Activity - On October 17, 康臣药业 repurchased 317,000 shares at a price range of HKD 14.970 to HKD 15.200, totaling HKD 4.7791 million [2] - The stock closed at HKD 15.070 on the same day, reflecting a decrease of 2.65% with a total trading volume of HKD 22.5955 million [2] - Since October 14, the company has conducted buybacks for four consecutive days, acquiring a total of 937,000 shares for a cumulative amount of HKD 14.368 million, during which the stock price fell by 5.81% [2] Year-to-Date Buyback Summary - Year-to-date, 康臣药业 has executed 22 buyback transactions, repurchasing a total of 6.132 million shares for a total expenditure of HKD 72.8991 million [2] Detailed Buyback Data - The buyback details include: - October 16: 200,000 shares at a maximum price of HKD 15.600, totaling HKD 3.1182 million [2] - October 15: 100,000 shares at a maximum price of HKD 15.840, totaling HKD 1.5757 million [2] - October 14: 320,000 shares at a maximum price of HKD 15.620, totaling HKD 4.8951 million [2] - Other notable buyback dates include July 18, July 16, and July 15, with varying amounts and prices [2][3]
康臣药业(01681.HK)10月17日回购31.70万股，耗资477.91万港元